DA Wallach Says AI Will Not Solve Biology Without Human Trials
DA Wallach explains why clinical translation caps AI drug discovery, why China leads preclinical biotech, and why trial speed drives pharma value.
The best ideas from 30+ top podcasts, every week.
The hosts break down current tech market volatility, blowout October jobs numbers, and reports that Tesla is winding down Cybertruck production. They also interview Figma CFO Praveer Melwani on the company's accelerating AI and MCP adoption, Zipline CEO Keller Cliffton on expanding drone delivery with Walmart, Julius AI founder Rahul Sonwalkar on benchmarking LLMs for Wall Street deals, Siegelman Stable founder Max Siegelman on scaling modern luxury streetwear, and investor DA Wallach on the realities of AI-driven biotechnology.
DA Wallach explains why clinical translation caps AI drug discovery, why China leads preclinical biotech, and why trial speed drives pharma value.
Figma CFO Praveer Melwani explains how doubling AI credit allotments and scaling an MCP server drove $391 million in quarterly revenue.
Julius AI tested frontier LLMs on messy M&A deals. Inkling 2 beat Nvidia Nemotron, while coding models failed basic finance checks.
Keller Cliffton details Zipline's $1.5B round, 300 Walmart Supercenters, and building 50,000 aircraft a year for 10x faster deliveries.
The week's best AI, tech, business, science, and culture podcasts in one short read. Free, every Sunday.
You get both newsletters, The Throughline and The Carry. No spam. Unsubscribe with one click.